Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6668 |
SGC-CBP30
|
Epigenetic Reader Domain; Histone Acetyltransferase | Chromatin/Epigenetic |
SGC-CBP30 是高选择性CBP/p300溴结构域的有效抑制剂,对CBP 和p300的Kd 值分别为 21 和 32 nM。它强烈减少 Th17 细胞中 IL-17A 的分泌,具有抗炎作用。 | |||
T77560 |
Histone acetyltransferase p300 Inhibitor 4c
|
Carbonic Anhydrase; AChE | Metabolism; Neuroscience |
Histone acetyltransferase p300 Inhibitor 4c 是2-氨基噻唑衍生物,Histone acetyltransferase p300 Inhibitor 4c 对 hCA I 、hCA II、AChE 和 BChE 具有抑制作用,Ki 值为 0.008 ± 0.001 、 0.124 ± 0.017、0.129 ± 0.030 和 0.083 ± 0.041 μM。 | |||
T1962 |
ASP3026
ASP 3026 |
Apoptosis; ALK | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
ASP3026 是一种选择性的,具有口服活性的间变性淋巴瘤激酶抑制剂,可诱导肿瘤细胞凋亡,可研究非小细胞肺癌。 | |||
T7264 |
CBP/EP300-IN-1
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
CBP/EP300-IN-1是一种 CBP/EP300 溴结构域抑制剂。 | |||
T12345 |
CBP/p300-IN-3
P300/CBP-IN-3 |
Histone Acetyltransferase | Chromatin/Epigenetic |
CBP/p300-IN-3 (P300/CBP-IN-3) 是一种组蛋白乙酰转移酶抑制剂。 | |||
TNU0864 |
HUP30
|
Potassium Channel; Calcium Channel | Membrane transporter/Ion channel; Metabolism |
HUP30是一种强效的血管舒张剂。HUP30可以刺激可溶性鸟苷酸环化酶,激活 K+离子通道,阻断细胞外 Ca2+的内流。 | |||
T36682 |
USP30 inhibitor 18
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP30 inhibitor 18 是有效的USP30选择性抑制剂,IC50为 0.02 μM。它增加蛋白质泛素化并加速线粒体自噬。 | |||
T13267 |
USP30 inhibitor 11
USP30-IN-11 |
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
USP30 inhibitor 11 (USP30-IN-11) 是一个选择性的 USP30 抑制剂(IC50 : 0.01 µΜ),抑制 SVA,可用于研究癌症、线粒体功能障碍和帕金森。 | |||
T41181 | iP300v | ||
iP300v is a negative control for iP300w | |||
T10702 |
CBP/p300-IN-2
CBP/EP300-IN-2 |
Epigenetic Reader Domain; c-Myc | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
CBP/EP300-IN-2 is an inhibitor of CBP/EP300 (IC50s: 1.07 nM and 5.96 nM for CBP/HTRF and Myc). | |||
T13191 |
TP3011
CH0793011 |
Others | Others |
TP3011 is a potent topoisomerase I inhibitor equipotent as SN38 and is an active metabolite of CH-0793076. | |||
T40144 |
CBP/p300 ligand 2
|
||
CBP/p300 ligand 2 is a selective ligand that binds to the target protein for PROTAC of dCBP-1, a potent and selective heterobifunctional degrader of p300/CBP. | |||
T40143 |
PROTAC CBP/P300 Degrader-1
PROTAC CBP/P300 Degrader-1 |
PROTACs | PROTAC |
PROTAC CBP/P300 Degrader-1 is an effective compound that degrades CBP/P300 in a potent manner. It significantly reduces cell viability in various cancer cell lines. | |||
T63767 | P300 bromodomain-IN-1 | ||
P300 bromodomain-IN-1 是 p300 (EP300) bromodomain 的有效抑制剂 (IC50: 49 nM)。P300 bromodomain-IN-1 能够阻碍 c-Myc 的表达,并诱导 OPM-2 细胞的细胞周期阻滞在 G1/G0 期及诱导其凋亡 (apoptosis)。 | |||
T62415 | CBP/p300-IN-17 | ||
CBP/p300-IN-17 (compound 7) 是一种 EP300/CBP HAT 的有效抑制剂,能够作用于 HAT EP300 (IC50: 0.18 μM) 和 LK2 H3K27 (IC50: 0.69 μM)。 | |||
T63565 |
CBP/p300-IN-19 hydrochloride
|
||
CBP/p300-IN-19 hydrochloride 是选择性的、有效的 p300/CBP HAT 抑制剂,能够作用于 p300-HAT (IC50: 1.4 μM)、CBP-HAT (IC50: 2.2 μM)、PCAF (IC50>100 μM)、Myst3 (IC50>100 μM)。CBP/p300-IN-19 hydrochloride 具有抗肿瘤作用。 | |||
T12346 |
CBP/p300-IN-5
P300/CBP-IN-5 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
P300/CBP-IN-5 is a potent inhibitor of p300/CBP histone acetyltransferase (IC50 of 18.8 nM). | |||
T73921 |
Ep300/CREBBP-IN-2
|
||
Ep300/CREBBP-IN-2 (Example 73) 是一种有效的和具有口服活性的Ep300和CREBBP 抑制剂,IC50分别为 0.052 μM 和 0.148 μM。Ep300/CREBBP-IN-2 可用于癌症研究。 | |||
T73922 |
Ep300/CREBBP-IN-3
|
||
Ep300/CREBBP-IN-3 (Example 61) 是一种有效的Ep300和CREBBP 抑制剂,IC50分别为 0.056 μM 和 0.095 μM。Ep300/CREBBP-IN-3 可用于癌症研究。 | |||
T63110 |
CBP/p300-IN-15
|
||
CBP/p300-IN-15 (compound 13a) 是一种有效的 p300 (IC50: 2.5 nM) 和 CBP (IC50: 28.0 nM) 抑制剂。CBP/p300-IN-15 能够较好的抑制 OVCAR-3 细胞 (EC50: 0.865 μM) 和 A2780 细胞 (EC50: 2.71 μM)。 CBP/p300-IN-15 能够用于研究卵巢癌。 | |||
T73920 |
Ep300/CREBBP-IN-8
|
||
Ep300/CREBBP-IN-8 (Example 37) 是一种有效的和具有口服活性的 Ep300和CREBBP 抑制剂,IC50分别为 0.014 μM 和 0.018 μM。Ep300/CREBBP-IN-8 可用于癌症研究。 | |||
T72815 |
CBP/p300-IN-10
|
||
CBP/p300-IN-10 是一种高效的组蛋白乙酰转移酶 EP300和CREBBP 的抑制剂,IC50分别为 26 nM 和 39 nM。 | |||
T63122 | CBP/p300-IN-19 | ||
CBP/p300-IN-19 是一种 p300/CBP HAT 的有效抑制剂,能够作用于 p300-HAT (IC50: 1.4 μM)、CBP-HAT (IC50: 2.2 μM)、PCAF (IC50>100 μM)、Myst3 (IC50>100 μM)。CBP/p300-IN-19 具有抗肿瘤活性。 | |||
T62720 | CBP/p300-IN-18 | ||
CBP/p300-IN-18 (compound 8) 是一种 EP300/CBP HAT 的有效抑制剂,能够作用于 HAT EP300 (IC50: 0.056 μM) 和 LK2 H3K27 (IC50: 0.46 μM)。 | |||
T40344 |
CBP/p300-IN-14
CBP/p300-IN-14 |
||
CBP/p300-IN-14, efficiently inhibits CBP/EP300 (lysine acetyltransferase) with an IC50 value of 3.3 nM. | |||
T39826 |
CBP/p300-IN-8
CBP/p300-IN-8 |
||
CBP/p300-IN-8 is a potent inhibitor of the CBP/P300 family of bromodomains . CBP/p300-IN-8 inhibits CBP ( IC 50 =0.01-0.1 μΜ) and BRD4 ( IC 50 =1-1000 μΜ) activity. | |||
T40142 |
Thalidomide-NH-CBP/p300 ligand 2
Thalidomide-NH-CBP/p300 ligand 2 |
PROTACs | PROTAC |
Thalidomide-NH-CBP/p300 ligand 2 (P-007) is a PROTAC-based compound designed to degrade CBP and p300, acting as a functional antagonist (WO2020173440). | |||
T73923 | Ep300/CREBBP-IN-4 | ||
Ep300/CREBBP-IN-4 (Example 56) 是一种有效的Ep300和CREBBP 抑制剂,IC50分别为 0.024 μM 和 0.064 μM。Ep300/CREBBP-IN-4 可用于癌症研究。 | |||
T79395 |
CBP/p300-IN-21
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
CBP/p300-IN-21 (Compound 5d) 作为一种选择性CBP/p300抑制剂,展现出对p300和CBP具有差异性的IC50值,分别为0.07 μM和1.755 μM。该化合物能有效降低H3K18Ac的水平,并抑制小鼠4T1肿瘤的生长。 | |||
T28439 |
PP30
PP 30,PP-30 |
||
PP30 is an inhibitor of mTORC1 and mTORC2. It is selective within the PI3K family, inhibiting other PI3Ks only at high concentrations. | |||
T62700 |
CBP/p300-IN-16
|
||
CBP/p300-IN-16 (compound 1) 是一种 EP300/CBP HAT 的有效抑制剂,作用于 HAT EP300 (IC50: 0.61 μM) 和 LK2 H3K27 (IC50: 2.24 μM)。 | |||
T23489 |
UBP301
UBP 301 |
Others | Others |
UBP301 is a kainate receptor antagonist. |